Showing results (281-290 of 296) with videos related to
Sort By:
Pageof 30
Microscopy Research and Technique|November 26, 1998
Neuronal and inducible nitric oxide synthase and nitrotyrosine immunoreactivities in the cerebral cortex of the aging ratL O Uttenthal, D Alonso, A P Fernández, et al.Journal of Investigational Allergology & Clinical Immunology|January 25, 2019
IgE-Mediated Sensitization to Galactose-α-1,3- Galactose (α-Gal) in Urticaria and Anaphylaxis in Spain: Geographical Variations and Risk FactorsM B Mateo Borrega, B Garcia, C H Larramendi, et al.Scientific Reports|July 2, 2020
Venom alkaloids against Chagas disease parasite: search for effective therapiesRafael C M Costa Silva, Eduardo G P Fox, Fabio M Gomes, et al.The Journal of Allergy and Clinical Immunology|January 8, 2008
Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxisDavid González de Olano, Iván Alvarez-Twose, María I Esteban-López, et al.Journal of Investigational Allergology & Clinical Immunology|March 3, 2004
Tolerance of a cluster schedule on the treatment of seasonal allergic respiratory disease with pollen extracts quantified in mass unitsC Moreno, L Fernández-Távora, S Acero, et al.The Journal of Allergy and Clinical Immunology|May 4, 2010
Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptomsIván Alvarez-Twose, David González de Olano, Laura Sánchez-Muñoz, et al.Blood Advances|January 13, 2022
Comparative outcomes for mature T-cell and NK/T-cell lymphomas in people with and without HIV and to AIDS-defining lymphomasMin Jung Koh, Mwanasha H Merrill, Min Ji Koh, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 28, 2025
Comparative Outcomes of Babesiosis in Immunocompromised and Non-Immunocompromised Hosts: A Multicenter Cohort StudyLoukas Kakoullis, Carolyn D Alonso, Rebecca Burns, et al.The Lancet. Infectious Diseases|April 16, 2023
Redefining Clostridioides difficile infection antibiotic response and clinical outcomesAnne J Gonzales-Luna, Andrew M Skinner, Carolyn D Alonso, et al.BMC Bioinformatics|April 13, 2018
Encompassing new use cases - level 3.0 of the HUPO-PSI format for molecular interactionsM Sivade Dumousseau, D Alonso-López, M Ammari, et al.Pageof 30